BACKGROUND: High genetic risk (HR) of atopy among unstratified populations of infants is associated with attenuated IFN-gamma responses. However, the role of IFN-gamma in progression from HR status to active disease is less clear. OBJECTIVE: To identify immune function markers in neonates with HR that are associated with positive atopic outcomes at 2 years. METHODS: Cord blood mononuclear cells (CBMCs) were collected from 175 children with HR and cryopreserved. The children were assessed for atopy by skin prick at 0.5 and 2 years. CBMCs were thawed and stimulated with allergens and mitogens PHA and staphylococcal enterotoxin B (SEB), and cytokine responses were determined. RESULTS: No correlations were observed between allergen-specific CBMC responses and atopic outcomes. In contrast, sensitization was strongly associated with polyclonal IFN-gamma responses to both PHA (P=.002) and SEB (P=.005), and also with SEB-induced IL-5 (P =.05), IL-10 (P =.02), and IL-13 (P =.01). Logistic regression analysis identified elevated PHA-induced IFN-gamma and SEB-induced IL-13 responses as the strongest independent predictors of atopy development. Cell separation studies confirmed CD8+ T cells as the source of approximately 90% of IFN-gamma production. CONCLUSIONS: IFN-gamma produced by CD8+ T cells may synergize with T(H)2 cytokines in driving atopy development in children with HR.
BACKGROUND: High genetic risk (HR) of atopy among unstratified populations of infants is associated with attenuated IFN-gamma responses. However, the role of IFN-gamma in progression from HR status to active disease is less clear. OBJECTIVE: To identify immune function markers in neonates with HR that are associated with positive atopic outcomes at 2 years. METHODS: Cord blood mononuclear cells (CBMCs) were collected from 175 children with HR and cryopreserved. The children were assessed for atopy by skin prick at 0.5 and 2 years. CBMCs were thawed and stimulated with allergens and mitogens PHA and staphylococcal enterotoxin B (SEB), and cytokine responses were determined. RESULTS: No correlations were observed between allergen-specific CBMC responses and atopic outcomes. In contrast, sensitization was strongly associated with polyclonal IFN-gamma responses to both PHA (P=.002) and SEB (P=.005), and also with SEB-induced IL-5 (P =.05), IL-10 (P =.02), and IL-13 (P =.01). Logistic regression analysis identified elevated PHA-induced IFN-gamma and SEB-induced IL-13 responses as the strongest independent predictors of atopy development. Cell separation studies confirmed CD8+ T cells as the source of approximately 90% of IFN-gamma production. CONCLUSIONS:IFN-gamma produced by CD8+ T cells may synergize with T(H)2 cytokines in driving atopy development in children with HR.
Authors: Ngoc P Ly; Sheryl L Rifas-Shiman; Augusto A Litonjua; Arthur O Tzianabos; Bianca Schaub; Begoña Ruiz-Pérez; Kelan G Tantisira; Patricia W Finn; Matthew W Gillman; Scott T Weiss; Diane R Gold Journal: Pediatrics Date: 2006-12-04 Impact factor: 7.124
Authors: Julie Rowe; Stephanie T Yerkovich; Peter Richmond; Devinda Suriyaarachchi; Elizabeth Fisher; Leonie Feddema; Richard Loh; Peter D Sly; Patrick G Holt Journal: Infect Immun Date: 2005-12 Impact factor: 3.441
Authors: Holly D Clifford; Stephanie T Yerkovich; Siew-Kim Khoo; Guicheng Zhang; John Upham; Peter N Le Souëf; Peter Richmond; Catherine M Hayden Journal: Immunogenetics Date: 2011-09-23 Impact factor: 2.846
Authors: Sabine Hoffjan; Dan Nicolae; Irina Ostrovnaya; Kathy Roberg; Michael Evans; Daniel B Mirel; Lori Steiner; Karen Walker; Peter Shult; Ronald E Gangnon; James E Gern; Fernando D Martinez; Robert F Lemanske; Carole Ober Journal: Am J Hum Genet Date: 2005-02-22 Impact factor: 11.025
Authors: Helene M Wolsk; Nilofar V Følsgaard; Sune Birch; Susanne Brix; Trevor T Hansel; Sebastian L Johnston; Tatiana Kebadze; Bo L Chawes; Klaus Bønnelykke; Hans Bisgaard Journal: J Infect Dis Date: 2015-12-09 Impact factor: 5.226
Authors: Tobias Strunk; Melanie R Power Coombs; Andrew J Currie; Peter Richmond; Douglas T Golenbock; Liat Stoler-Barak; Leighanne C Gallington; Michael Otto; David Burgner; Ofer Levy Journal: PLoS One Date: 2010-04-09 Impact factor: 3.240
Authors: Kaharu Sumino; Jennifer Tucker; Muhammad Shahab; Katy F Jaffee; Cynthia M Visness; James E Gern; Gordon R Bloomberg; Michael J Holtzman Journal: J Allergy Clin Immunol Date: 2012-03-27 Impact factor: 10.793